Turbovax Inc
TurboVax Inc. was founded on June 26, 2023, by Dr. Kishore R. Alugupalli, PhD, Associate professor of Microbiology, and Immunology, Thomas Jefferson University, Philadelphia, PA, USA. Dr. Alugupalli currently is the fulltime CEO of TurboVax Inc, and is interested in commercialization of a ground-breaking vaccine adjuvant named Turbo. The major goal of TurboVax Inc is to partner with vaccine manufacturing or vaccine developing companies and organizations. The incorporation of Turbo as an adjuvant will significantly improve the immunogenicity and efficacy of polysaccharide subunit vaccines and help prevent bacterial infections globally.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Turbovax Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
Showing 1 of 2 verified contacts
Top roles at Turbovax Inc
2 distinct titles indexed · top 2 shown.
- 1founder, chairman, ceo
- 1regulatory affairs specialist
Sign up to unlock all 2 contacts at Turbovax Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Turbovax Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.